Clinical Trial

Inspiris Resilia Durability Registry

Study acronym: INDURE
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective, open-label, multicenter, European registry with a follow-up of 5 years to assess the clinical outcomes of patients younger than 60 years who undergo surgical AVR with the INSPIRIS RESILIA Aortic Valve™.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2018-09-11; most recent amendment 2025-06-11.
Status change: Recruiting → Active, Not Recruiting 2021-12-20
Status change: Not Yet Recruiting → Recruiting 2019-07-26
Trial Details
NCT Number NCT03666741
Lead Sponsor Institut für Pharmakologie und Präventive Medizin
Collaborators: Edwards Lifesciences
Conditions Aortic Valve Stenosis
Enrollment 400 participants
Start Date 2019-04-26
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-06-15